| The value of 11C-5-hydroxy-tryptophan positron emission tomography in neuroendocrine tumor diagnosis and management: experience fromone center. | |
| | |
MedLine Citation:
|
PMID: 20332708 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Many neuroendocrine tumors (NET) are small and may escape localization by conventional imaging techniques. In such cases, 11C-5-hydroxy-tryptophan (11C-5-HTP) positron emission tomography (PET) has been tested as an additional diagnostic tool. Nine patients with clinically, biochemically and/or histologically confirmed NET and negative computerized tomography (CT) or magnetic resonance imaging (MRI), and 111In-pentetreotide (Octreoscan) scintigraphy underwent imaging with 11C-5-HTP-PET/CT in order to: 1) detect the primary tumor lesion in three patients; 2) detect residual disease in two patients with appendiceal carcinoid, one with rectal carcinoid, one with midgut carcinoid, and one with ectopic ACTH secretion (EAS) due to residual pulmonary carcinoid; and 3) restage a patient with medullary thyroid carcinoma (MTC) and hepatic metastases. 11C-5-HTP-PET/CT detected lesions in the mediastinum in a patient with EAS due to a pulmonary carcinoid, further hepatic metastases in a patient with carcinoid syndrome (CS) from a NET of unknown primary, further hepatic metastases in the patient with MTC, and hepatic metastases in the patient with midgut carcinoid. The 11C-5-HTP-PET/CT findings contributed to radical cure of the patient with recurrent EAS, and pointed towards bilateral adrenalectomy in the patient with EAS without evident primary tumor. In addition, 11C-5- HTP-PET/CT directed towards combined surgical and medical treatment in the patient with CS and multiple rather than single hepatic metastases and in the patient with midgut carcinoid, and towards continuation of medical treatment in the patient with MTC. 11C-5-HTP-PET/CT is a useful imaging technique, providing additional information for the diagnosis, staging and decision-making regarding management of patients with NET. |
| | |
Authors:
|
A Nikolaou; D Thomas; C Kampanellou; K Alexandraki; L G Andersson; A Sundin; G Kaltsas |
Related Documents
:
|
19847358 - How to choose pet-ct or ct in the diagnosis and staging of lung cancer. practical exper... 17515398 - Thymic extension in the superior mediastinum in patients with thymic hyperplasia: poten... 19590618 - The current role of pet-ct in the characterization of hepatobiliary malignancies. 16467718 - Fluorodeoxyglucose-positron emission tomography/computed tomography imaging in patients... 20635328 - The prevalence and clinical significance of (18) f-2-fluoro-2-deoxy-d-glucose (fdg) upt... 20153148 - Short-te proton magnetic resonance spectroscopy investigation in adolescents with atten... |
Publication Detail:
|
Type: Journal Article Date: 2010-03-22 |
Journal Detail:
|
Title: Journal of endocrinological investigation Volume: 33 ISSN: 1720-8386 ISO Abbreviation: J. Endocrinol. Invest. Publication Date: 2010 Dec |
Date Detail:
|
Created Date: 2011-02-03 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7806594 Medline TA: J Endocrinol Invest Country: Italy |
Other Details:
|
Languages: eng Pagination: 794-9 Citation Subset: IM |
Affiliation:
|
Endocrine Unit, Department of Pathophysiology, National University of Athens, Mikras Asias 75, 15575 Athens, Greece. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Spermatogenesis in Klinefelter syndrome.
Next Document: Association analysis of polymorphisms in IL-3, IL-4, IL-5, IL-9, and IL-13 with Graves' disease.